Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0222 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
filingDate |
1986-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47ce47223b27bfb76b237dc27cb6e14c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2e6d4624f2aaf67dd83a4ebdba50b9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cb3729b65365bcb045a0eea5415c2ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ede1f19a079527f70f3cbb3d374d845 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66377024fdd5b01dfd72ed3eff2b113c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40c8eb5e701e4b702e8c83a1be929cd3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_557790a377fc7515641e7c78988286bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b384a034818f8e672abf5d8c10f9b218 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18415aa8c5b5fd3c54f2bccc8a160bb3 |
publicationDate |
1986-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0192393-A2 |
titleOfInvention |
Alkylaminofuranone derivatives |
abstract |
The present invention relates to a compound of formula (I)whereinR' represents methyl or a group of the formula R<sup>3</sup>-NH-/CH<sub>2</sub>)<sub>4</sub>- wherein R<sup>3</sup> is hydrogen or a protective group compatible with the peptide bond,R<sup>2</sup> represents hydrogen, a protective group compatible with the peptide bond or a cation derived from an organic or inorganic base; pharmaceutically acceptable salts and diastereomers thereof.The compounds of the invention are useful for inhibiting the effect of the angiotensin-converting enzyme and they can be used in therapy as blood pressure reducing agents and for the treatment of cardiac failure and glaucoma. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0240914-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0240914-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4876359-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-398424-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-880100546-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0266568-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5120644-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0266568-A3 |
priorityDate |
1985-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |